Un nuevo tratamiento contra el VIH ha probado ser un éxito. ¿Será accesible en África?news2022-09-30T09:00:20+00:00September 30th, 2022|The New York Times|
FDA Approves ALS Treatment Despite Questions About Effectivenessnews2022-09-29T21:14:36+00:00September 29th, 2022|The New York Times|
A New Shot Guards Against H.I.V., but Access for Africans Is Uncertainnews2022-09-27T07:00:12+00:00September 27th, 2022|The New York Times|
Monkeypox Shots, Treatments and Tests Are Unavailable in Much of the Worldnews2022-09-12T11:30:34+00:00September 12th, 2022|The New York Times|
Samples of Popular Diabetes Drug Contain Potential Carcinogen, F.D.A. Saysnews2022-08-11T19:37:20+00:00August 11th, 2022|The New York Times|
Allergan Reaches Tentative $2.37 Billion Deal to Settle Opioid Suitsnews2022-07-29T17:08:24+00:00July 29th, 2022|The New York Times|
Cancer Drug Greatly Reduces Deaths in Hospitalized Covid Patientsnews2022-07-06T11:00:10+00:00July 6th, 2022|The New York Times|
En Brasil, las mujeres tienen que adquirir las píldoras abortivas de los narcotraficantesnews2022-06-29T07:00:13+00:00June 29th, 2022|The New York Times|
When Abortion Pills Were Banned in Brazil, Women Turned to Drug Traffickersnews2022-06-28T07:00:14+00:00June 28th, 2022|The New York Times|
Abortion Pills Take the Spotlight as States Impose Abortion Bansnews2022-06-26T07:00:11+00:00June 26th, 2022|The New York Times|
